ANI PHARMACEUTICALS INC 10-Q filing
Filed 2025-11-07 · Report date 2025-09-30 · 2025
Filing metadata
- Accession number
- 0001023024-25-000108
- Form type
- 10-Q
- CIK
- 0001023024
- Primary document
- https://www.sec.gov/Archives/edgar/data/1023024/000102302425000108/anip-20250930.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for ANI PHARMACEUTICALS INC.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $636.3M | - | - |
| Operating Income | $76.3M | - | - |
| Net Income | $50.8M | - | - |
| Eps Basic | 2.26 | - | - |
| Eps Diluted | 2.15 | - | - |
| Cash And Equivalents | $262.6M | - | - |
| Total Assets | $1.4B | - | - |
| Total Liabilities | $902.3M | - | - |
| Shareholders Equity | $505.8M | - | - |
| Operating Cash Flow | $154.9M | - | - |
| Capital Expenditures | $12.6M | - | - |